Preclinical Trial-on-Chip Real-Time Imaging Service for CAR-T

Current CAR-T development for solid tumors faces significant hurdles, including limited spatial-temporal resolution, physiologically irrelevant 2D models, and the high cost and low predictability of traditional animal studies. Creative Biolabs' Preclinical Trial-on-Chip Real-Time Imaging Service for CAR-T directly addresses these gaps by offering a transformative evaluation platform. We provide continuous, high-resolution visualization of CAR-T cell dynamics, including tumor infiltration, trafficking, and killing kinetics, within sophisticated, immunocompetent organ-on-chip models that faithfully replicate the human tumor microenvironment.

Introduction

CAR-T therapy shows promise in hematologic cancers but faces challenges in solid tumors, particularly in tracking real-time cell behavior. Traditional monitoring methods lack spatial and dynamic resolution. The integration of advanced molecular imaging with innovative preclinical trial-on-chip enables continuous, non-invasive visualization of CAR-T cell trafficking, tumor infiltration, and functional activity, providing essential insights to optimize therapeutic strategies and accelerate translation to solid tumor immunotherapy.

Fig.1 Direct and genetic labeling techniques in real-time cell tracking and biodistribution studies.¹

Preclinical Trial-on-Chip Real-Time Imaging Service for CAR-T at Creative Biolabs

Creative Biolabs offers a paradigm-shifting solution to close the critical translation gap between in vitro promise and in vivo efficacy. We deliver high-fidelity, human-relevant data that quantitatively maps how your CAR-T cells overcome the multifaceted barriers of the complex tumor microenvironment (TME). Our microscale chip platforms recapitulate human pathophysiological conditions, generating actionable insights into cell trafficking, multi-killing potency, and functional persistence dynamics.

What We Can Offer

Our integrated service platform delivers unprecedented, real-time visual and quantitative insights into CAR-T cell function within physiologically relevant tumor models.

Our Service Process

Required Starting Materials:

• CAR-T Cell Product: Purified engineered T-cells with specific vector details.
• Target Tumor Cells: Cell lines or patient-derived tumor cells (organoids).
• Experimental Parameters: Desired TME conditions.

Key Steps:

Final Deliverables:

• Subcellular-Resolution Temporal Imaging: Continuous time-lapse recordings capturing dynamic CAR-T cell interactions with tumor targets at subcellular detail.
• Multiparametric Functional Profiling: Quantitative analysis of key effector metrics, including serial killing capacity, migratory kinetics, and immune synapse durability.

Key Advantages

• Customized Microphysiological Design: All tissue-specific chip architectures and associated protocols undergo formal review and approval by our dedicated quality assurance team to ensure physiological fidelity to your target organ.
• Genetically Encoded Signaling Analysis: We incorporate genetically encoded biosensors to enable real-time, high-resolution visualization and validation of intracellular signaling cascades and kinase dynamics in CAR-T cells.
• Sustained Kinetic Profiling: Our platform ensures the robust stability of 3D co-cultures, enabling continuous, long-term observation (24+ hours) to capture critical slow-kinetic phenotypes, such as functional exhaustion.

FAQs

Why Choose Us?

Creative Biolabs delivers an unmatched window into CAR-T cell mechanisms. Our proprietary platform provides "Digital Biopsies"—capturing dynamic interactions with isotropic subcellular clarity and quantifying hundreds of concurrent events in a human-relevant setting. This reveals foundational biology to de-risk candidate selection and power decisive clinical translation.

Customer Reviews

How to Contact Us?

Gain unparalleled, dynamic insights into your CAR-T cell function with our industry-leading imaging platform. To request a customized project proposal or a technical consultation, please contact our dedicated imaging specialists. We are ready to help you visualize success and de-risk your therapeutic development path.

Reference

1. Shao, Fuqiang et al. "Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring." Theranostics vol. 11,14 6800-6817. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.7150/thno.56989.